Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity

Abstract

Purpose. To assess the potential of chitosan (CS) nanoparticles for ocular drug delivery by investigating their interaction with the ocular mucosa in vivo and also their toxicity in conjunctival cell cultures. Methods. Fluorescent (CS-fl) nanoparticles were prepared by ionotropic gelation. The stability of the particles in the presence of lysozyme was investigated by determining the size and their interaction with mucin, by measuring the viscosity of the mucin dispersion. The in vivo interaction of CS-fl nanoparticles with the rabbit cornea and conjunctiva was analyzed by spectrofluorimetry and confocal microscopy. Their potential toxicity was assessed in a human conjunctival cell line by determining cell survival and viability. Results. CS-fl nanoparticles were stable upon incubation with lysozyme and did not affect the viscosity of a mucin dispersion. In vivo studies showed that the amounts of CS-fl in cornea and conjunctiva were significantly higher for CS-fl nanoparticles than for a control CS-fl solution, these amounts being fairly constant for up to 24 h. Confocal studies suggest that nanoparticles penetrate into the corneal and conjunctival epithelia. Cell survival at 24 h after incubation with CS nanoparticles was high and the viability of the recovered cells was near 100%. Conclusions. CS nanoparticles are promising vehicles for ocular drug delivery.

Chitosan Nanoparticles of 5-Fluorouracil for Ophthalmic Delivery: Characterization, in-Vitro and in-Vivo Study

“…This unique combination of properties makes it a novel versatile biopolymer, which fulfils the requirement for its application in the ophthalmic field. 8,9) Based on these considerations, we hypothesized that a colloidal suspension of 5-FU loaded DNPs will increase the residence time of the drug in the precorneal area due to its mucoadhesive property and prolong the penetration of the drug into the intraocular structures, making it suitable the ophthalmic application.…”

Natural Polysaccharide based Nanoparticles for Drug/Gene Deliv­ery

“…Hence, chitosan based systems are attractive candidates for use in ocular delivery. 43 Besides, chitosan can be modified by specific targeting ligands for the rapid and efficient interaction of carrier with cell membranes.…”

Lipid-core nanocapsules: mechanism of self-assembly, control of size and loading capacity

“…The high concentration of polysorbate 80 coating in A 0.4 could promote the formation of micelles of surfactant, whose agglomerate led to an increase in D [4,3]. The best formulation was A 4 (B 4 ) having D [4,3] of 243 nm and span of 1.63.…”

“…The best formulation was A 4 (B 4 ) having D [4,3] of 243 nm and span of 1.63. Considering these data, series B was prepared, taking into account the proportionality of A 4 (1.0 : 4.1 : 2.6 : 2.0 of PCL, SM, CCT and polysorbate 80, respectively).…”